Short answer
Apogee Therapeutics, Inc. (APGE) filed an 8-K current report with the SEC on April 24, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Andrew Gottesdiener, M.D. and Peter Harwin resigning from Apogee’s Board effective May 11, 2026.
Apogee Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Andrew Gottesdiener, M.D. and Peter Harwin resigning from Apogee’s Board effective May 11, 2026
- Board size reduced from nine directors to seven, lowering director coverage and governance capacity
- Resignations unrelated to disagreements over operations, policies, or practices
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Apogee Therapeutics, Inc. 8-K filings
Get the next APGE 8-K as it lands
Follow APGE for push alerts, or ask the research agent what this filing means.